Standard
Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer. / Burford, B; Gentry-Maharaj, A; Graham, R; Allen, D; Pedersen, J W; Nudelman, A S; Blixt, Klas Ola; Fourkala, E O; Bueti, D; Dawnay, A; Ford, J; Desai, R; David, L; Trinder, P; Acres, B; Schwientek, T; Gammerman, A; Reis, C A; da Silva, Lara Patricia Marcos; Osório, H; Hallett, R; Wandall, H H; Mandel, U; Hollingsworth, M A; Jacobs, I; Fentiman, I; Clausen, H; Taylor-Papadimitriou, J; Menon, U; Burchell, J M.
In:
B J C, Vol. 108, No. 10, 28.05.2013, p. 2045-55.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Burford, B, Gentry-Maharaj, A, Graham, R, Allen, D, Pedersen, JW, Nudelman, AS, Blixt, KO, Fourkala, EO, Bueti, D, Dawnay, A, Ford, J, Desai, R, David, L, Trinder, P, Acres, B, Schwientek, T, Gammerman, A, Reis, CA, da Silva, LPM, Osório, H, Hallett, R
, Wandall, HH, Mandel, U, Hollingsworth, MA, Jacobs, I, Fentiman, I
, Clausen, H, Taylor-Papadimitriou, J, Menon, U & Burchell, JM 2013, '
Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer',
B J C, vol. 108, no. 10, pp. 2045-55.
https://doi.org/10.1038/bjc.2013.214APA
Burford, B., Gentry-Maharaj, A., Graham, R., Allen, D., Pedersen, J. W., Nudelman, A. S., Blixt, K. O., Fourkala, E. O., Bueti, D., Dawnay, A., Ford, J., Desai, R., David, L., Trinder, P., Acres, B., Schwientek, T., Gammerman, A., Reis, C. A., da Silva, L. P. M., ... Burchell, J. M. (2013).
Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer.
B J C,
108(10), 2045-55.
https://doi.org/10.1038/bjc.2013.214Vancouver
Burford B, Gentry-Maharaj A, Graham R, Allen D, Pedersen JW, Nudelman AS et al.
Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer.
B J C. 2013 May 28;108(10):2045-55.
https://doi.org/10.1038/bjc.2013.214Author
Burford, B ; Gentry-Maharaj, A ; Graham, R ; Allen, D ; Pedersen, J W ; Nudelman, A S ; Blixt, Klas Ola ; Fourkala, E O ; Bueti, D ; Dawnay, A ; Ford, J ; Desai, R ; David, L ; Trinder, P ; Acres, B ; Schwientek, T ; Gammerman, A ; Reis, C A ; da Silva, Lara Patricia Marcos ; Osório, H ; Hallett, R ; Wandall, H H ; Mandel, U ; Hollingsworth, M A ; Jacobs, I ; Fentiman, I ; Clausen, H ; Taylor-Papadimitriou, J ; Menon, U ; Burchell, J M. / Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer. In: B J C. 2013 ; Vol. 108, No. 10. pp. 2045-55.
Bibtex
@article{f953015c6aa942d981f689e088cb876b,
title = "Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer",
abstract = "Autoantibodies have been detected in sera before diagnosis of cancer leading to interest in their potential as screening/early detection biomarkers. As we have found autoantibodies to MUC1 glycopeptides to be elevated in early-stage breast cancer patients, in this study we analysed these autoantibodies in large population cohorts of sera taken before cancer diagnosis.",
author = "B Burford and A Gentry-Maharaj and R Graham and D Allen and Pedersen, {J W} and Nudelman, {A S} and Blixt, {Klas Ola} and Fourkala, {E O} and D Bueti and A Dawnay and J Ford and R Desai and L David and P Trinder and B Acres and T Schwientek and A Gammerman and Reis, {C A} and {da Silva}, {Lara Patricia Marcos} and H Os{\'o}rio and R Hallett and Wandall, {H H} and U Mandel and Hollingsworth, {M A} and I Jacobs and I Fentiman and H Clausen and J Taylor-Papadimitriou and U Menon and Burchell, {J M}",
year = "2013",
month = may,
day = "28",
doi = "10.1038/bjc.2013.214",
language = "English",
volume = "108",
pages = "2045--55",
journal = "The British journal of cancer. Supplement",
issn = "0007-0920",
publisher = "nature publishing group",
number = "10",
}
RIS
TY - JOUR
T1 - Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer
AU - Burford, B
AU - Gentry-Maharaj, A
AU - Graham, R
AU - Allen, D
AU - Pedersen, J W
AU - Nudelman, A S
AU - Blixt, Klas Ola
AU - Fourkala, E O
AU - Bueti, D
AU - Dawnay, A
AU - Ford, J
AU - Desai, R
AU - David, L
AU - Trinder, P
AU - Acres, B
AU - Schwientek, T
AU - Gammerman, A
AU - Reis, C A
AU - da Silva, Lara Patricia Marcos
AU - Osório, H
AU - Hallett, R
AU - Wandall, H H
AU - Mandel, U
AU - Hollingsworth, M A
AU - Jacobs, I
AU - Fentiman, I
AU - Clausen, H
AU - Taylor-Papadimitriou, J
AU - Menon, U
AU - Burchell, J M
PY - 2013/5/28
Y1 - 2013/5/28
N2 - Autoantibodies have been detected in sera before diagnosis of cancer leading to interest in their potential as screening/early detection biomarkers. As we have found autoantibodies to MUC1 glycopeptides to be elevated in early-stage breast cancer patients, in this study we analysed these autoantibodies in large population cohorts of sera taken before cancer diagnosis.
AB - Autoantibodies have been detected in sera before diagnosis of cancer leading to interest in their potential as screening/early detection biomarkers. As we have found autoantibodies to MUC1 glycopeptides to be elevated in early-stage breast cancer patients, in this study we analysed these autoantibodies in large population cohorts of sera taken before cancer diagnosis.
U2 - 10.1038/bjc.2013.214
DO - 10.1038/bjc.2013.214
M3 - Journal article
C2 - 23652307
VL - 108
SP - 2045
EP - 2055
JO - The British journal of cancer. Supplement
JF - The British journal of cancer. Supplement
SN - 0007-0920
IS - 10
ER -
